Postgraduate Research Scholarship in Monoclonal Antibodies

This Scholarship has been established to provide financial assistance to a PhD student who is undertaking research in a project in 'Novel Predictive Tools for the Selection and Engineering of Aggregation-Resistant Biologics Mainly Therapeutic Monoclonal Antibodies.' The scholarship provides a stipend allowance for up to 3 years to support doctoral research at the Faculty of Medicine and Health at the University of Sydney. This Scholarship is funded by Boehringer Ingelheim Pharmaceuticals, Inc. The successful applicant will conduct research focused on developing novel predictive tools for selecting and engineering aggregation-resistant biologics, with a primary focus on therapeutic monoclonal antibodies. Recipients must be domestic students enrolled full-time in a PhD program and are required to submit all publications, presentations and their thesis to the funder for approval before publishing.